Indianapolis-based Eli Lilly, along with two other European pharmaceutical companies, is facing a price-fixing lawsuit regarding its rapidly escalating insulin prices.

What healthcare reform will look like a year from now is unknown but thousands of people are enrolling in the ACA for 2017 coverage.

In a letter, Vermont Sen. Bernie Sanders and Maryland Rep. Elijah Cummings criticize three insulin manufacturers -- including Indianapolis-based Eli Lilly -- for skyrocketing insulin prices.

Last week the Obama administration announced new rates on the federal marketplace will rise an average of 22 percent nationwide. That reported increase, though, is only based on one benchmark Silver plan, which is used to calculate federal subsidies.

The ruling leaves in place a trial court and state appeals court decision that ruled a hospital will have to release information about how it charges and offers discounts to insured patients.

Earlier this year, United Healthcare announced it was exiting Indiana's individual marketplace, and last month, Fort Wayne-based Physicians Health Plan of Northern Indiana followed suit.

The nonprofit will continue to sell small group plans, but is dropping all its individual products, both on and off the Affordable Care Act marketplace.

If completed, the Anthem-Cigna merger could be among the largest in history. But before the takeover happens, the companies need to prove the deal won't violate federal anti-trust laws.

Anthem's deal with Connecticut-based Cigna had been in the works for more than a year. However, in recent months experts started speculating about the feasibility of the $48 billion merger, reasoning the deal could potentially violate anti-trust laws.

In May, the Indiana Family and Social Services Administration announced it was planning to lower the amount of money home health care workers would get through the Medicaid program - as much as 8 percent for registered nurses and 6 percent for home health aides. Now the state has decided to keep the 2016 rates intact.